𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A Novel RET Kinase- -Catenin Signaling Pathway Contributes to Tumorigenesis in Thyroid Carcinoma

✍ Scribed by Gujral, T. S.; van Veelen, W.; Richardson, D. S.; Myers, S. M.; Meens, J. A.; Acton, D. S.; Dunach, M.; Elliott, B. E.; Hoppener, J. W.M.; Mulligan, L. M.


Book ID
118120250
Publisher
American Association for Cancer Research
Year
2008
Tongue
English
Weight
533 KB
Volume
68
Category
Article
ISSN
0008-5472

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Fusion of a novel gene, ELKS, to RET due
✍ Tomoko Nakata; Yutaka Kitamura; Kazuo Shimizu; Shigeo Tanaka; Minoru Fujimori; S πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 144 KB πŸ‘ 1 views

In papillary thyroid carcinomas, the genes for receptor-type tyrosine kinase, RET or TRKA, are sometimes rearranged, resulting in fusion of its tyrosine kinase domain to 5Ј portions of several activating genes. In a papillary thyroid carcinoma, we identified a novel gene (ELKS), the 5Ј portion of wh

Involvement of hepatocyte epidermal grow
✍ Ziqiu Wang; Meifang Wang; Brian I. Carr πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 173 KB πŸ‘ 3 views

Compound 5 (Cpd 5), a synthetic K vitamin analogue, or 2-(2-mercaptoethanol)-3-methyl-1,4-naphthoquinone, is a potent inhibitor of epidermal growth factor (EGF)-induced rat hepatocyte DNA synthesis and induces EGF receptor (EGFR) tyrosine phosphorylation. To understand the cellular responses to Cpd

Erratum to β€œMolecular cloning and mRNA e